Inhaled Niclosamide a Potential Effective Antiviral to Treat COVID-19

An infrared image of nasal spray being administered.
September 29, 2020
Researchers in the lab of Dr. Hugh D.C. Smyth have released promising results of a new method to treat SARS-CoV-2, the coronavirus that causes COVID-19. The antiviral niclosamide, when incorporated with human lysozyme as a carrier molecule, shows potential as an effective COVID-19 treatment when delivered directly to the airways.

Brown inducted into Provost’s Distinguished Service Academy

Brown Headshot
February 4, 2020
Health Outcomes Professor Carolyn Brown, Ph.D. was one of five accomplished faculty members at The University of Texas at Austin to be inducted into the first cohort of the Provost’s Distinguished Service Academy (DSA).